EHR-integrated rUTI Texting Platform (Urotrust)
An EHR-integrated Texting Platform to Promote Self-management in Women With Recurrent Urinary Tract Infections
Sponsor: Independence Blue Cross
This NA trial investigates Recurrent Urinary Tract Infection and is currently completed. Independence Blue Cross leads this study, which shows 8 recorded versions since 2024 — indicating limited longitudinal coverage. Longitudinal tracking of infectious disease trials helps identify durability of treatment effects.
Status Flow
Change History
8 versions recorded-
Sep 2025 — Present [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
Jul 2025 — Sep 2025 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
Oct 2024 — Jul 2025 [monthly]
Recruiting NA
-
Sep 2024 — Oct 2024 [monthly]
Recruiting NA
-
Jul 2024 — Sep 2024 [monthly]
Recruiting NA
▶ Show 3 earlier versions
-
Apr 2024 — Jul 2024 [monthly]
Recruiting NA
-
Nov 2023 — Apr 2024 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
-
Oct 2023 — Nov 2023 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Independence Blue Cross
- University of Pennsylvania
For direct contact, visit the study record on ClinicalTrials.gov .